Amyris to buy women’s wellness firm MenoLabs

The acquisition will help accelerate the company’s growth and establish a footprint in the menopause market.

Previously, Amyris announced plans to establish a new consumer brand to offer science-backed, wellness and personal care products for the menopause market this year.

MenoLabs is focused on addressing perimenopause and menopause symptoms and offers all-natural treatments for menopause symptoms.

The company has launched eight products over the last two years. MenoFit, an all-natural menopause relief supplement, is said to be a major product among them.

By penetrating retail channels this year, MenoLabs intends to further expand its omnichannel presence. Currently, it earns subscription-based, recurring revenue stream through its online site.

The company has also introduced a perimenopause and menopause health tracker app, MenoLife, to help users to track and examine over 40 menopause-related symptoms.

Amyris CEO and president John Melo said: “We are committed to empowering women and creating a platform to support them with our leading science and wellness technology platform. Women deserve products and solutions that work during this period in their lives.